Skip to content

Antibody response in healthcare workers vaccinated with live-attenuated recombinant Japanese encephalitis chimeric vaccine

Antibody response in healthcare workers vaccinated with live-attenuated recombinant Japanese encephalitis chimeric vaccine

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
TCTR
Registry ID
TCTR20151203001
Enrollment
Unknown
Registered
2015-12-03
Start date
2015-10-15
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Japanese encephalitis risk Japanese encephalitis antibody response vaccination adults healthcare workers Thailand

Interventions

None listed

Sponsors

Sanofi Pasteur, Thailand
Lead Sponsor
Queen Sirikit National Institute of Child Health
Collaborator

Eligibility

Sex/Gender
All
Age
21 Years to 60 Years

Inclusion criteria

Inclusion criteria: Medical personnel who have risk factors of inadequate JE antibody, and voluntarily join the study

Exclusion criteria

Exclusion criteria: - Who did not provided informed consent to a blood test - People with high fever, acute illness - People with a history of allergy vaccines - Patients with chronic diseases such as heart, liver, kidney, which is in severe or complications within one year - who are immunocompromised, women during lactation

Design outcomes

Primary

MeasureTime frame
levels of antibody response vaccinated Japanese encephalitis Upon enrollment Blood samples for levels of antibodies after vaccination against Japanese encephalitis

Secondary

MeasureTime frame
proportion and predictors of antibody response Upon enrollment dates and levels of antibody response

Countries

Thailand

Contacts

Public ContactWarunee Vandepitte

QSNICH

waruneep@gmail.com+66-85-515-8299

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026